Clinical Trial Update: An Open Label, Study of DaxibotulinumtoxinA for Migraine Prevention

View source ↗

Summary

An open-label clinical trial evaluating daxibotulinumtoxinA for migraine prevention; the current study status is unknown. Sponsor: Ki Health Partners LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• DaxibotulinumtoxinA (daxibotulinumtoxinA)

Snippet

Sponsor: Ki Health Partners. LLC | Conditions: Migraine Disorders | Status: UNKNOWN